Table 2.

Effect of PAF Treatment on the Ability of BMSC to Support CFU-GM Colony Formation From Autologous CD34+ Cells

Culture ConditionsExp 1Exp 2Exp 3Exp 4
Control 15 ± 1* 39 ± 6 19 ± 1 17 ± 7 
PAF 39 ± 5 52 ± 9 14 ± 6 22 ± 2 
WEB2170 16 ± 3 41 ± 4 11 ± 4 21 ± 4 
PAF + WEB2170 16 ± 2 45 ± 2 10 ± 4 21 ± 2 
Control + anti-PRL 17 ± 3 33 ± 4 10 ± 3 18 ± 5 
PAF + anti-PRL 24 ± 4 49 ± 7 19 ± 2 24 ± 4 
WEB2170 + anti-PRL 18 ± 2 38 ± 6 11 ± 2 19 ± 3 
PAF + WEB2170 + anti-PRL 26 ± 3 40 ± 4 11 ± 7 20 ± 2 
Culture ConditionsExp 1Exp 2Exp 3Exp 4
Control 15 ± 1* 39 ± 6 19 ± 1 17 ± 7 
PAF 39 ± 5 52 ± 9 14 ± 6 22 ± 2 
WEB2170 16 ± 3 41 ± 4 11 ± 4 21 ± 4 
PAF + WEB2170 16 ± 2 45 ± 2 10 ± 4 21 ± 2 
Control + anti-PRL 17 ± 3 33 ± 4 10 ± 3 18 ± 5 
PAF + anti-PRL 24 ± 4 49 ± 7 19 ± 2 24 ± 4 
WEB2170 + anti-PRL 18 ± 2 38 ± 6 11 ± 2 19 ± 3 
PAF + WEB2170 + anti-PRL 26 ± 3 40 ± 4 11 ± 7 20 ± 2 

Abbreviations: anti-PRL, rabbit antiserum to human prolactin; WEB2170, PAF receptor antagonist.

*

Data represent the mean ± SD number of CFU-GM colonies per well in triplicate cultures each seeded with 5 × 102 cells. Cultures were performed in the presence of IL-3, GM-CSF, and Epo. No nonspecific inhibition was observed when using a nonimmune rabbit antiserum (not shown).

or Create an Account

Close Modal
Close Modal